Detalhe da pesquisa
1.
The utility of H2 receptor antagonists in preventing infusion-related reactions to paclitaxel chemotherapy.
Cancer
; 129(23): 3815-3819, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665180
2.
Potential Life-Years Lost: The Impact of the Cancer Drug Regulatory and Funding Process in Canada.
Oncologist
; 25(1): e130-e137, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31506392
3.
Oral targeted therapy for the treatment of non-small cell lung carcinoma.
CMAJ
; 196(16): E558-E561, 2024 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38684283
4.
A prospective intervention to improve happiness and reduce burnout in oncologists.
Support Care Cancer
; 27(4): 1563-1572, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30506102
5.
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
Lancet Oncol
; 19(4): 521-536, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545095
6.
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
Lancet Oncol
; 19(7): 904-915, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29804902
7.
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.
Breast Cancer Res Treat
; 167(3): 659-669, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29058175
8.
Involvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes.
Curr Oncol
; 31(2): 1028-1034, 2024 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38392070
9.
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices.
Curr Oncol
; 31(5): 2453-2480, 2024 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38785465
10.
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.
Nat Med
; 30(3): 716-729, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38351187
11.
The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study.
Breast Cancer Res Treat
; 141(1): 111-7, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23942873
12.
Prospective validation of a prediction tool for identifying patients at high risk for chemotherapy-induced nausea and vomiting.
J Support Oncol
; 11(1): 14-21, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22763232
13.
Medical Assistance in Dying in Patients With Cancer.
JCO Oncol Pract
; 19(9): 819-827, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37582243
14.
What Attributes Matter Most in Physicians? Exploratory Findings from a Single-Centre Survey of Stakeholder Priorities in Cancer Care at a Canadian Academic Cancer Centre.
Curr Oncol
; 30(9): 8363-8374, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37754522
15.
Management of Very Early Small Cell Lung Cancer: A Canadian Survey Study.
Curr Oncol
; 30(7): 6006-6018, 2023 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37504310
16.
Real-World Immunotherapy Use and Effectiveness in Advanced NSCLC With Programmed Death-Ligand 1 Greater Than or Equal to 50% and Greater Than or Equal to 90.
JTO Clin Res Rep
; 4(12): 100601, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38162175
17.
Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial.
Curr Oncol
; 30(4): 3817-3828, 2023 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185402
18.
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer.
Curr Oncol
; 30(7): 6289-6315, 2023 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37504325
19.
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC.
Curr Oncol
; 30(7): 6473-6496, 2023 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37504336
20.
Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World Experience.
Curr Oncol
; 30(7): 6559-6574, 2023 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37504341